Nicola is the Global Translational Science Liaison for Horizon Discovery Ltd., where she has worked for the past 6 years. Nicola’s role involves scientific input to the wider business on the use of gene editing and gene modulation and how this can best be used to aid Pharmaceutical companies in the pursuit of new therapeutic targets in a variety of diseases. Prior to working at Horizon Discovery, Nicola worked for Nature Publishing Group (now Springer Nature) as an Associate, Senior and Chief Editor for Nature Reviews Cancer. Nicola has 10 years of postdoctoral research experience studying apoptosis (programmed cell death) in the context of cancer research and cardiovascular research and studied human anatomy for her B.Sc. and programmed cell death for her Ph.D. at the University of Birmingham, UK.